• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human BCL9 Polyclonal Antibody

The antibody against BCL9 was raised in rabbit using the Recombinant Human B-cell CLL/lymphoma 9 protein (231-340AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC, IF.

ADC-02878A

The antibody against BCL9 was raised in rabbit using the Recombinant Human B-cell CLL/lymphoma 9 protein (231-340AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB, IHC, IF.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-02878A ClonalityPolyclonal
Host SpeciesRabbitTarget NameBCL9
Target SynonymsBCL9B-cell CLL/lymphoma 9 protein antibody; B-cell lymphoma 9 protein antibody; Bcl-9 antibody; Protein legless homolog antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4Purification Method>95%, Protein G purified
ConjugateNon-conjugatedApplicationELISA, IF, IHC, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human B-cell CLL/lymphoma 9 protein (231-340AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDO00512
Background Information
  • Uniprot Id

    O00512

  • Target Species

    Human

  • Target Name

    BCL9

  • Target Full Name

    B-cell CLL/lymphoma 9 protein

  • Target Function

    Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity.

  • Target Involvement

    A chromosomal aberration involving BCL9 is found in a patient with precursor B-cell acute lymphoblastic leukemia (ALL). Translocation t(1;14)(q21;q32). This translocation leaves the coding region intact, but may have pathogenic effects due to alterations in the expression level of BCL9. Several cases of translocations within the 3'-UTR of BCL9 have been found in B-cell malignancies.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    BCL9 family

  • Target Tissue Specificity

    Detected at low levels in thymus, prostate, testis, ovary and small intestine, and at lower levels in spleen, colon and blood.

  • Target Synonyms

    BCL9B-cell CLL/lymphoma 9 protein; B-cell lymphoma 9 protein; Bcl-9; Protein legless homolog

  • Target Background

    BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Inquire Rabbit anti-Human BCL9 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification